Key facts
- This page summarizes Victor M. Moyo's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 27 Oct 2023, 16:41.
Victor M. Moyo - 02 Oct 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)
- Reporting relationship
- CHIEF MEDICAL OFFICER
- Issuer ticker
- TRAW
- Reported as of
- 02 Oct 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Mark Guerin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Victor M. Moyo filed Form 4 for Onconova Therapeutics, Inc. (TRAW) on 27 Oct 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ONTX
transaction
Derivative
Stock Option (right to purchase)
Award
- Transaction value
- $0
- Shares
- +125,000
- Change %
- Price
- $0.000000
- Shares after
- 125,000
- Date
- 02 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 125,000
- Exercise price
- $0.7400
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.